RCOR [AMEX]
Renovacor, Inc.
Index- P/E- EPS (ttm)-1.44 Insider Own7.40% Shs Outstand10.52M Perf Week-19.67%
Market Cap34.79M Forward P/E- EPS next Y-1.64 Insider Trans74.17% Shs Float10.47M Perf Month-45.71%
Income-14.10M PEG- EPS next Q-0.39 Inst Own43.90% Short Float2.22% Perf Quarter-65.06%
Sales- P/S- EPS this Y- Inst Trans-0.20% Short Ratio21.17 Perf Half Y-77.13%
Book/sh5.09 P/B0.39 EPS next Y0.00% ROA-17.20% Target Price21.00 Perf Year-80.73%
Cash/sh4.44 P/C0.44 EPS next 5Y- ROE-22.00% 52W Range1.95 - 10.74 Perf YTD-74.55%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-81.75% Beta-
Dividend %- Quick Ratio20.00 Sales past 5Y- Gross Margin- 52W Low0.51% ATR0.26
Employees19 Current Ratio20.00 Sales Q/Q- Oper. Margin- RSI (14)23.30 Volatility10.20% 8.86%
OptionableNo Debt/Eq0.00 EPS Q/Q-161.70% Profit Margin- Rel Volume0.27 Prev Close1.99
ShortableNo LT Debt/Eq0.44 EarningsMay 12 AMC Payout- Avg Volume11.00K Price1.96
Recom1.50 SMA20-37.73% SMA50-50.59% SMA200-72.79% Volume2,977 Change-1.51%
Oct-14-21Initiated Ladenburg Thalmann Buy $22
Oct-01-21Initiated Chardan Capital Markets Buy $20
May-12-22 04:05PM  
Mar-28-22 07:30AM  
Mar-24-22 04:15PM  
Mar-01-22 04:05PM  
Feb-28-22 04:05PM  
Jan-03-22 04:05PM  
Dec-23-21 12:38PM  
Nov-15-21 04:05PM  
Oct-04-21 04:05PM  
Sep-28-21 04:05PM  
Sep-22-21 04:05PM  
Sep-07-21 04:30PM  
Renovacor, Inc., a preclinical stage gene-therapy company, focuses on developing a pipeline of gene therapies for diseases in the areas of high unmet medical need associated with mutations in the Bcl2-associated athanogene 3 (BAG3) gene. The company's lead product candidate, REN-001, is a recombinant AAV9-based gene therapy to deliver a functional BAG3 gene to augment BAG3 protein levels in cardiomyocytes and slow or halt progression of BAG3 DCM. It focuses on the treatment of BAG3-associated dilated cardiomyopathy or BAG3 DCM, a heritable rare disease. The company was founded in 2013 and is based in Greenwich, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RTW INVESTMENTS, LP10% OwnerJan 18Buy8.0044,440355,5203,000,803Jan 20 05:00 PM
RTW INVESTMENTS, LP10% OwnerJan 14Buy8.00150,7231,205,4362,956,363Jan 14 06:13 PM
RTW INVESTMENTS, LP10% OwnerJan 13Buy7.752862,2162,805,640Jan 14 06:13 PM
RTW INVESTMENTS, LP10% OwnerJan 12Buy7.671,95014,9572,805,354Jan 14 06:13 PM
RTW INVESTMENTS, LP10% OwnerJan 06Buy8.0051,296410,3682,803,404Jan 06 07:43 PM
RTW INVESTMENTS, LP10% OwnerJan 05Buy8.00100,195801,5302,752,108Jan 06 07:43 PM
RTW INVESTMENTS, LP10% OwnerJan 04Buy8.004312,651,913Jan 06 07:43 PM
RTW INVESTMENTS, LP10% OwnerJan 03Buy7.954413,5062,647,981Jan 03 09:09 PM
RTW INVESTMENTS, LP10% OwnerDec 30Buy8.003,74329,9442,647,540Jan 03 09:09 PM
RTW INVESTMENTS, LP10% OwnerDec 29Buy8.004793,8322,643,797Jan 03 09:09 PM
RTW INVESTMENTS, LP10% OwnerDec 27Buy7.994,90539,2092,643,318Dec 28 06:57 PM
RTW INVESTMENTS, LP10% OwnerDec 23Buy7.9761,584490,9782,638,413Dec 28 06:57 PM
RTW INVESTMENTS, LP10% OwnerDec 22Buy7.953,50027,8302,576,829Dec 22 06:07 PM
RTW INVESTMENTS, LP10% OwnerDec 21Buy8.005,47343,7652,573,329Dec 22 06:07 PM
RTW INVESTMENTS, LP10% OwnerDec 20Buy7.96130,3161,037,4192,567,856Dec 22 06:07 PM
RTW INVESTMENTS, LP10% OwnerNov 17Buy9.0021,161190,4472,437,540Nov 17 08:00 PM
RTW INVESTMENTS, LP10% OwnerNov 16Buy9.0042,410381,6902,416,379Nov 17 08:00 PM
RTW INVESTMENTS, LP10% OwnerNov 15Buy9.014,32038,9022,373,969Nov 17 08:00 PM
RTW INVESTMENTS, LP10% OwnerNov 12Buy8.506315,3642,544,649Nov 12 07:49 PM
RTW INVESTMENTS, LP10% OwnerNov 11Buy8.443192,6912,544,018Nov 12 07:49 PM
RTW INVESTMENTS, LP10% OwnerNov 09Buy8.258,94973,8292,543,699Nov 12 07:49 PM
RTW INVESTMENTS, LP10% OwnerNov 08Buy8.25100,009825,0742,534,750Nov 08 06:39 PM
RTW INVESTMENTS, LP10% OwnerNov 05Buy8.3714,287119,6112,434,741Nov 08 06:39 PM
RTW INVESTMENTS, LP10% OwnerNov 04Buy8.0357,914464,9922,420,454Nov 08 06:39 PM